Citius Oncology, Inc. (CTOR)
Nasdaq: CTOR · Pharmaceutical Preparations · Cranford, NJ · filing with the SEC since 2021
Who runs Citius Oncology, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Mazur Leonard L
Chief Executive Officer. First filing Aug 2024, latest Nov 12, 2026, 0 filings in all.
Officers reporting now
4
of 11 people with a filing in the last fifteen months
Directors reporting now
7
15 people on the record since 2022
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Mazur Leonard L | Chief Executive Officer | Aug 2024 | Nov 12, 2026 | none |
| Bartushak Jaime | Chief Financial Officer | Aug 2024 | Nov 12, 2026 | none |
| Czuczman Myron | Chief Medical Officer | Aug 2024 | Nov 12, 2026 | none |
| Holubiak Myron Z | Secretary | Aug 2024 | Nov 12, 2026 | none |
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Peri Jonathan | director | Aug 2026 | Aug 14, 2026 | none |
| Dutia Suren G | director | Aug 2024 | Dec 22, 2025 | none |
| Holuka Eugene Myron | director | Aug 2024 | Dec 22, 2025 | none |
| Mayersohn Joel David | director | Oct 2022 | Dec 22, 2025 | none |
| Mcgrath Dennis M | director | Aug 2024 | Dec 22, 2025 | none |
| Smith Robert Joseph | director | Aug 2024 | Dec 22, 2025 | none |
| Webb Carol | director | Aug 2024 | Dec 22, 2025 | none |
Earlier names on the record6, newest filing first
Citius Pharmaceuticals, Inc. · 10% owner · last filing Aug 2024Yuan Xiaofeng · officer · last filing Oct 2022Zhang Dahe · officer · last filing Oct 2022Hartzband Brian Shawn · director · last filing Oct 2022Jiang Cathy · director · last filing Oct 202210xyz Management LLC · 10% owner · last filing Oct 2022
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.